Stay updated on Pembrolizumab in Lymphoma Subtypes Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Lymphoma Subtypes Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page’s footer “Revision” value was updated from v3.5.2 to v3.5.3, indicating a minor platform/version change without altering study details.
    Difference
    0.0%
    Check dated 2026-04-24T05:52:48.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Version bump from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:25:51.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    - Added inclusion criterion: B-cell lymphoma unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma.
    Difference
    0.0%
    Check dated 2026-04-02T14:59:47.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A new revision, v3.5.0, has been added; the previous revision, v3.4.3, has been removed.
    Difference
    0.0%
    Check dated 2026-03-19T00:01:38.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3 and no longer shows Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T20:08:03.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Page updated to Revision: v3.4.2. The previous funding-status notice (v3.4.1) and related operating-status messaging have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:09:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Lymphoma Subtypes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.